鈥檚 main research commercialisation company, , is promoting more than 35 cutting-edge medical innovations at the in Sydney this week.
鈥淲e are showcasing new drug delivery mechanisms, diagnostic and screening devices, clinical practice tools, and assistive technologies for allied health and rehabilitation,鈥� said UniQuest managing director .
More than 300 stakeholders in the Australian and international medical devices and diagnostics sector attend AusMedtech 2012. The two-day event (14-15 May) 鈥� run by by 鈥� is regarded as Australia's premier medical technology conference and includes an Investment Summit and Trade Exhibition.
Mr Henderson said UniQuest delegates were hosting a Trade Exhibition booth.
鈥淎usMedtech provides excellent opportunities for us to connect with potential commercial partners and investors while showcasing the exciting innovations being developed at 国产探花,鈥� he said.
鈥淎ustralian university researchers are addressing global health issues 鈥� such as quality care access, aging populations, and preventable diseases 鈥� which are hot topics for investors and global companies looking to help launch the next blockbuster medical innovation.
鈥淯niQuest鈥檚 medical technology portfolio includes innovations from 国产探花, University of Technology Sydney, University of Wollongong, Mater Medical Research Institute, James Cook University, University of Tasmania, and Queensland Health,鈥� he said.
鈥淭his single point of access to such a scale of research resources helps boost the capability profile of all our partner institutions.鈥�
Global medical technology is one of the world鈥檚 fastest growing markets, currently valued at US$300 billion a year. UniQuest-licensed innovations 鈥� which generate annual sales of more than A$3 billion globally 鈥� range from vaccines such as Gardasil to high-tech MRI machines and telehealth systems.
Media enquiries: Leanne Wyvill, UniQuest, +61 7 3365 4037, 0409 767 199 or l.wyvill@uniquest.com.au
About UniQuest Pty Limited http://www.uniquest.com.au.
Established by The University of Queensland in 1984, UniQuest is widely recognised as one of Australia鈥檚 largest and most successful university commercialisation groups, benchmarking in the top tier of technology transfer worldwide. From an intellectual property portfolio of 1500+ patents it has created over 70 companies, and since 2000 UniQuest and its start-ups have raised more than A$450 million to take university technologies to market. Annual sales of products using 国产探花 technology and licensed by UniQuest are running at A$3 billion. UniQuest now commercialises innovations developed at The University of Queensland including the Institute for Molecular Bioscience and its commercialisation partner institutions: the University of Wollongong, University of Technology Sydney, James Cook University, University of Tasmania, Mater Medical Research Institute, and Queensland Health. A recent addition to the company is the Queensland Government-supported ilab technology business incubator and accelerator. UniQuest also provides access to an expansive and exclusive network of independent academics to tailor a consulting or project R&D solution to meet the diverse needs of industry and government, facilitating some 500 consulting, expert opinion, testing, and contract research services each year. UniQuest is also a leading Australasian provider of international development assistance recognised for excellence in technical leadership, management and research. Working with agencies such as AusAID, NZAID, the Asian Development Bank and the World Bank, UniQuest has developed and implemented more than 400 projects in 60+ countries throughout the Pacific, South-East Asia, the Indian sub-continent and Africa.
